跳至主要内容
临床试验/ITMCTR1900002645
ITMCTR1900002645尚未招募1 期

An optimized clinical treatment strategy and its mechanisms for Shen-Qi Sequential Therapy in the prevention and treatment of Diabetic Macrovascular Diseases based on the TCM theory of Latent Pathogen

Hospital of Chengdu University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
35 至 75(—)
性别
All

入选标准

  • To be included in the study, patients must have:
  • (1) Diagnosis of LEAD of diabetes as well as Qi-yin deficiency with blood stasis syndrome according to WM and TCM;
  • (2) According to Fontaine stage of LEAD, patients with stage I, IIa and IIb are eligible;
  • (3) Aged between 35 and 75 years;
  • (4) HbA1c <= 9.0%;
  • (5) Women of childbearing age are required negative pregnancy test and agree to use reliable contraception measures during the study;
  • (6) Voluntarily participate in the test and sign the informed consent;

排除标准

  • Patients will be excluded from the study if they meet any of the following criteria:
  • (1) Patients with cardiac and renal insufficiency, acute coronary syndrome, cerebrovascular accident, vasculitis, venous dysfunction of lower limbs, hematopoietic system disorders and mental diseases;
  • (2) Patients with acute metabolic disorders such as diabetic ketoacidosis within the past 1 month;
  • (3) Severe infection in the past 1 month;
  • (4) Patients with allergic constitution;
  • (5) Uncooperative in run-in period;
  • (6) Having a history of alcoholism or drug abuse;
  • (7) A history of another clinical study in the previous 3 months;
  • (8) Patients considered by the investigator to be unfit for this study.

研究者

发起方
Hospital of Chengdu University of Traditional Chinese Medicine

相似试验